Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (581-590 of 993) with videos related to

Pageof 100
Sort By:
The Journal of Urology|June 19, 2009
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasiaClaudio Jeldres, Hendrik Isbarn, Umberto Capitanio, et al.
Clinical Genitourinary Cancer|December 15, 2021
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary BladderMarina Kosiba, L Franziska Stolzenbach, Claudia Collà Ruvolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance)Matthew R Smith, Susan Halabi, Charles J Ryan, et al.
Urologic Oncology|July 21, 2020
Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancerMarina Deuker, L Franziska Stolzenbach, Claudia Collà Ruvolo, et al.
European Urology Focus|September 23, 2020
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based StudyMarina Deuker, L Franziska Stolzenbach, Claudia Collà Ruvolo, et al.
European Urology Oncology|November 5, 2025
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate CancerFred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
Future Oncology (London, England)|June 30, 2025
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language reviewPaul E Dato, Jose De La Cerda, Andrew J Armstrong, et al.
Urologia Internationalis|July 15, 2026
Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after NephroureterectomyMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.
Plos One|August 15, 2022
Developing practice guidelines to integrate physical activity promotion as part of routine cancer care: A knowledge-to-action protocolIsabelle Doré, Audrey Plante, Nathalie Bedrossian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancerJohann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Pageof 100

Showing results (581-590 of 993) with videos related to

Sort By:
Pageof 100
The Journal of Urology|June 19, 2009
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasiaClaudio Jeldres, Hendrik Isbarn, Umberto Capitanio, et al.
Clinical Genitourinary Cancer|December 15, 2021
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary BladderMarina Kosiba, L Franziska Stolzenbach, Claudia Collà Ruvolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance)Matthew R Smith, Susan Halabi, Charles J Ryan, et al.
Urologic Oncology|July 21, 2020
Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancerMarina Deuker, L Franziska Stolzenbach, Claudia Collà Ruvolo, et al.
European Urology Focus|September 23, 2020
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based StudyMarina Deuker, L Franziska Stolzenbach, Claudia Collà Ruvolo, et al.
European Urology Oncology|November 5, 2025
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate CancerFred Saad, Andrew J Armstrong, Mototsugu Oya, et al.
Future Oncology (London, England)|June 30, 2025
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language reviewPaul E Dato, Jose De La Cerda, Andrew J Armstrong, et al.
Urologia Internationalis|July 15, 2026
Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after NephroureterectomyMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.
Plos One|August 15, 2022
Developing practice guidelines to integrate physical activity promotion as part of routine cancer care: A knowledge-to-action protocolIsabelle Doré, Audrey Plante, Nathalie Bedrossian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancerJohann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Pageof 100